Malaria: Clinical Trials

159 trials for Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

159 completed. 159 Phase 3, 25 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3159Completed 159
Phase 225Completed 25

Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria

Trials (filtered) newest first · largest first

All 159 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Parasite Clearance and Protection From Infection (PCPI) in Zambia
SP (Macleods Pharmaceuticals Ltd), AS (Guilin Pharmaceuticals) - Malaria
Phase 3CompletedLondon School of Hygiene and Tropical Medicine6002024-07-242025-03-12
Parasite Clearance and Protection From Infection (PCPI) in Cameroon
SP (Macleods Pharmaceuticals Ltd), SPAQ (Guilin Pharmaceuticals), AS (Guilin Pharmaceuticals) - Malaria
Phase 3CompletedLondon School of Hygiene and Tropical Medicine9022024-06-102025-03-12
Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria
KLU156, Coartem - Uncomplicated Plasmodium Falciparum Malaria
Phase 3CompletedNovartis Pharmaceuticals17202024-03-072026-11-04
Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities
Mesh - spatial repellent impregnated with transfluthrin (2500mg), Information and Education Campaigns (IEC), test and treat malaria cases - Malaria, Childhood ALL
Phase 3CompletedThe Mentor Initiative24002023-06-052024-04-23
Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial
Artemether-lumefantrine and Amodiaquine Drug Combination, Artemether-lumefantrine then Artesunate amodiaquine, Artemether-lumefantrine - Uncomplicated Plasmodium Falciparum Malaria
Phase 2 / Phase 3CompletedMuhimbili University of Health and Allied Sciences3842023-05-012026-09-23
Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)
Albendazole Pill, Ivermectin Pill, Ivermectin Injectable Product - Malaria
Phase 3CompletedBarcelona Institute for Global Health481452022-03-172025-03-14
A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)
Artemether-lumefantrine+amodiaquine, Artemether-lumefantrine+placebo, Artesunate-mefloquine+piperaquine - Plasmodium Falciparum Malaria (Uncomplicated)
Phase 3CompletedUniversity of Oxford1032021-06-302024-03-20
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
Sulfadoxine pyrimethamine, Pyramax - Malaria in Pregnancy
Phase 3CompletedUniversity of Kinshasa2502021-05-062022-11-04
Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine
Tafenoquine, Primaquine - Vivax Malaria, Plasmodium Vivax
Phase 3CompletedMenzies School of Health Research9602021-04-252024-10-08
Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia
Dihydroartemisinin Piperaquine - Sickle Cell Anemia in Children, Malaria
Phase 3CompletedLiverpool School of Tropical Medicine7232021-04-092023-09-13
Improving Care Through Azithromycin Research for Infants in Africa
Azithromycin, Placebo - Child Mortality
Phase 3CompletedBarcelona Institute for Global Health205602021-03-152026-11-06
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
Artemether-lumefantrine (AL), Pyronaridine-artesunate (PA) - Covid-19, Malaria
Phase 3CompletedLiverpool School of Tropical Medicine1432021-01-082024-02-23
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
Sulfadoxine-pyrimethamine (SP), Dihydroartemisinin-piperaquine (DP) - Malaria
Phase 3CompletedGrant Dorsey, M.D, Ph.D.27572020-12-282025-11-06
A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.
Artemether-lumefantrine+ Amodiaquine (AL+AQ), Artemether-lumefantrine + placebo (AL+PBO), Artesunate-mefloquine+piperaquine (AS-MQ+PPQ) - Plasmodium Falciparum Malaria (Uncomplicated)
Phase 3CompletedUniversity of Oxford25832020-09-012025-11-18
Additional Screening With Sensitives RDTs and Malaria
Additional screening using ultra sensitive RDTs, Dihydroartemisinin-piperaquin, Reminders - Plasmodium Falciparum Malaria, Malaria Diagnosis
Phase 3CompletedInstitut de Recherche en Sciences de la Sante, Burkina Faso3402020-08-312023-03-30
Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study
Tetanus/diphtheria toxoids, SMC with SP+AQ, RTS,S/AS01 - Malaria,Falciparum, Child, Only
Phase 3CompletedLondon School of Hygiene and Tropical Medicine50982020-04-012024-09-20
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
Intermittent Preventive Therapy with Dihydroartemisinin-Piperaquine - Pregnancy; HIV; Malaria
Phase 3CompletedLiverpool School of Tropical Medicine8982019-11-112023-08-22
Improving Maternal heAlth by Reducing Malaria in African HIV Women
Dihydroartemisinin-piperaquine (DHA-PPQ), Placebo Oral Tablet - Malaria, HIV/AIDS
Phase 3CompletedBarcelona Institute for Global Health6662019-09-182024-10-01
Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission
Pyronaridine Tetraphosphate/Artesunate, Dihydroartemisinin/Piperaquine, Primaquine Diphosphate - Malaria,Falciparum
Phase 2 / Phase 3CompletedLondon School of Hygiene and Tropical Medicine1002019-09-122020-01-30
Repeat Ivermectin Mass Drug Administrations for MALaria Control II
Ivermectin, Placebo oral tablet - Malaria
Phase 3CompletedBrian Foy41242019-07-132025-04-10

Showing 20 of 159. Sign in to see all of them.

Narrower conditions

Malaria, Falciparum (47)  ·  Malaria, Vivax (14)  ·  Anemia (7)  ·  HIV Infections (5)  ·  Anemia, Sickle Cell (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Glucosephosphate Dehydrogenase Deficiency (2)  ·  Hemolysis (2)  ·  Infections (2)  ·  Malaria, Cerebral (2)  ·  Protozoan Infections (2)  ·  Recurrence (2)  ·  Anemia, Hemolytic (1)  ·  Asymptomatic Infections (1)

Broader conditions

Mosquito-Borne Diseases (159)  ·  Parasitic Diseases (158)  ·  Vector Borne Diseases (158)  ·  Infections (157)  ·  Protozoan Infections (157)  ·  Hemic and Lymphatic Diseases (14)  ·  Hematologic Diseases (13)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Communicable Diseases (9)  ·  Genital Diseases (9)  ·  Urogenital Diseases (9)  ·  Virus Diseases (9)  ·  Blood-Borne Infections (8)  ·  Immune System Diseases (8)

Interventions

Artemether, Lumefantrine Drug Combination (33)  ·  fanasil, pyrimethamine drug combination (31)  ·  Chloroquine (22)  ·  Artesunate (17)  ·  Amodiaquine (16)  ·  Primaquine (16)  ·  amodiaquine, artesunate drug combination (11)  ·  Azithromycin (10)  ·  pyronaridine tetraphosphate, artesunate drug combination (9)  ·  piperaquine (7)  ·  Mefloquine (6)  ·  chloroguanil, dapsone drug combination (6)  ·  Ivermectin (5)  ·  Pyrimethamine (4)  ·  Vitamin A (4)

Sponsors

London School of Hygiene and Tropical Medicine (43)  ·  University of Oxford (12)  ·  GlaxoSmithKline (10)  ·  University of California, San Francisco (9)  ·  Institute of Tropical Medicine, Belgium (6)  ·  Liverpool School of Tropical Medicine (5)  ·  Medicines for Malaria Venture (5)  ·  Pfizer (5)  ·  Menzies School of Health Research (4)  ·  Barcelona Institute for Global Health (3)  ·  Institut de Recherche pour le Developpement (3)  ·  Centers for Disease Control and Prevention (2)  ·  Grant Dorsey, M.D, Ph.D. (2)  ·  Indiana University (2)  ·  Makerere University (2)

Countries

Burkina Faso (28)  ·  Uganda (24)  ·  Kenya (23)  ·  Ghana (17)  ·  Tanzania (16)  ·  Mali (14)  ·  The Gambia (12)  ·  Mozambique (9)  ·  Nigeria (9)  ·  Democratic Republic of the Congo (8)  ·  Gabon (7)  ·  Malawi (7)  ·  Senegal (7)  ·  Thailand (7)  ·  Cambodia (6)

Top investigators

Grant Dorsey, MD, PhD (6)  ·  Diane V Havlir, MD (4)  ·  Brian Greenwood, FRCP, FRS (3)  ·  Brian Greenwood, MD (3)  ·  Jayaram Menon, MBBS (3)  ·  Paul J Milligan, PhD (3)  ·  Tsin Yeo, MBBS (3)  ·  Alassane Dicko, Professor (2)  ·  Arjen Dondorp, MD (2)  ·  Badara Cisse, PhD (2)  ·  Brian D. Foy, PhD (2)  ·  Bridget Barber, MBBS (2)  ·  Clara Menendez, MD, PhD (2)

Results publications

PMID 23433102, PMID 26666916, PMID 39324693, PMID 21849081, PMID 22993389, PMID 25425434, PMID 29547881, PMID 33020153, PMID 35732155, PMID 36534705, PMID 12510893, PMID 16503464, PMID 16551365, PMID 16640611, PMID 17046467, PMID 17239256, PMID 17519409, PMID 17519410, PMID 17940319, PMID 17971864, PMID 18074034, PMID 18171245, PMID 18213379, PMID 18237394, PMID 18522503, PMID 18547415, PMID 18547416, PMID 18582194, PMID 18598190, PMID 18620950, PMID 18682739, PMID 18752443, PMID 18926569, PMID 19038036, PMID 19098989, PMID 19199542, PMID 19352498, PMID 19366448, PMID 19505304, PMID 19656069, PMID 19690618, PMID 19765815, PMID 19765816, PMID 19769536, PMID 19784374, PMID 19789648, PMID 19843332, PMID 19877969, PMID 19948038, PMID 20209126

NIH funding

P01HD059454 (2), R01AI104702 (1), U01AI126610 (1), U01AI138910 (1)